Patents and SPCs are not the only protection for, and incentive system that encourages, pharmaceutical innovation. Regulatory exclusivities play an increasingly important role, indeed so much so that they can often determine which patents are at potential risk of challenge.  This webinar will address the two most important such exclusivities in Europe—that protecting the data filed in order to secure a marketing authorization for a new medicinal product (Data Exclusivity, or Regulatory Data Protection) and that providing market exclusivity as against similar medicinal products for the same indication where such indication is so rare that the medicinal product in issue has secured an orphan designation.

WilmerHale Partner Trevor Cook will lead this discussion.